The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical comparison of ABP 215 and bevacizumab in patients with NSCLC: Pharmacokinetic results and justification for extrapolation across bevacizumab indications.
 
Nick Thatcher
Honoraria - Amgen; Boehringer Ingelheim; Lilly; Otsuka; Roche
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Lilly; Otsuka
Speakers' Bureau - Amgen; Boehringer Ingelheim; Lilly; Otsuka; Roche
Expert Testimony - Lilly
 
Michael Thomas
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Zhiying Pan
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Jerome H. Goldschmidt
Employment - Blue Ridge Cancer Care
Leadership - Blue Ridge Cancer Care
Honoraria - Bristol-Myers Squibb; Celgene; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Michael Schenker
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Mylan; Novartis; Pfizer; Roche; Synta; Teva
 
Rebeca Melara
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Vladimir Hanes
Employment - Amgen
Stock and Other Ownership Interests - Amgen